The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


KNIGHT THERAPEUTICS Inc closed at $10.18.

Over the last five days, shares have gained 6.82%, but are down 5.21% for the last year to date. Shares have outperformed the S&P TSX by 16.38% during the last year.

Key company metrics

  • Trailing P/E55.60×
  • P/E 1 year forward61.70×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.18
Updated June 22 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Total other revenue--------
Total revenue2221
Gross profit1121
Total cost of revenue0001
Total operating expense-6-6-5-4
Selling / general / administrative3322
Research & development0101
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--000
Other operating expenses, total00-20
Operating income8875
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax8875
Income after tax6864
Income tax, total1021
Net income6864
Total adjustments to net income--------
Net income before extra. items6864
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6864
Inc. avail. to common incl. extra. items6864
Diluted net income6864
Dilution adjustment--------
Diluted weighted average shares144135133113
Diluted EPS excluding extraordinary itemsvalue per share0.
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.